Selective Killing of Cells with Oxidative Defects in Galactose Medium: a Screening Test for Affected Patient Fibroblasts
Overview
Authors
Affiliations
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
Carbo J, Cornet-Masana J, Cuesta-Casanovas L, Delgado-Martinez J, Banus-Mulet A, Clement-Demange L Cancers (Basel). 2023; 15(6).
PMID: 36980800 PMC: 10047683. DOI: 10.3390/cancers15061912.
Nedara K, Reinhardt C, Lebraud E, Arena G, Gracia C, Buard V Front Oncol. 2022; 12:958155.
PMID: 36387192 PMC: 9661196. DOI: 10.3389/fonc.2022.958155.
Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.
Kuszak A, Espey M, Falk M, Holmbeck M, Manfredi G, Shadel G Annu Rev Pathol. 2017; 13:163-191.
PMID: 29099651 PMC: 5911915. DOI: 10.1146/annurev-pathol-020117-043644.
Kopajtich R, Nicholls T, Rorbach J, Metodiev M, Freisinger P, Mandel H Am J Hum Genet. 2014; 95(6):708-20.
PMID: 25434004 PMC: 4259976. DOI: 10.1016/j.ajhg.2014.10.017.
Pitceathly R, Rahman S, Wedatilake Y, Polke J, Cirak S, Foley A Cell Rep. 2013; 3(6):1795-805.
PMID: 23746447 PMC: 3701321. DOI: 10.1016/j.celrep.2013.05.005.